AKR1C1 and non-small cell lung carcinoma: In summary, the results in this study suggest that AKR1C1 is an important prognostic biomarker that may predict long-term survival in NSCLC patients, which can regulate the proliferation and migration of NSCLC cells and promote the occurrence of ferroptosis.